Skip to main content
. Author manuscript; available in PMC: 2015 Jan 28.
Published in final edited form as: J Neurochem. 2014 Sep 19;132(1):85–98. doi: 10.1111/jnc.12934

Table 2. Relative level of FABP mRNAs in NGFDPC12 cells with and without PAM treatment.

Relative abundance of selected FABPs in NGFDPC12 cells (without PAM-LTx) was determined by real-time RT-PCR, using GAPDH as the reference gene. Ct: threshold cycle. The amount of mRNA in experimental cells was calculated using 2−ΔΔCT method. Their mRNA changes upon PAM treatment are represented as mRNA level of PAM-treated cells/ mRNA level of control-treated cells.

E-FABP I-FABP H-FABP A-FABP B-FABP M-FABP
Ct(FABP)-Ct(GAPDH) 0.00±0.27 8.72±2.15 9.93±0.56 11.69±2.20 11.76±4.73 10.10±2.88
Relative Abundance 1042.81±196.69 5.51±4.95 1.11±0.32 0.73±0.67 3.95±4.00 3.45±3.48
PAM/CTL (fold) 3.06±0.90 1.18±0.66 1.77±1.40 4.71±2.18 1.03±0.57 1.48±0.80